Empery Asset Management »

Sellas Life Sciences Group I shares owned by Empery Asset Management

Quarter-by-quarter ownership of Sellas Life Sciences Group I (SLS) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Sellas Life Sciences Group I

Tip: Access up to 7 years of quarterly data

All positions including Sellas Life Sciences Group I held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sellas Life Sciences Group I by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $623k 309k 2.02
2022-06-30 $2.1M 928k 2.23

More positions owned by Empery Asset Management

89bio (ETNB)
Unity Biotechnology
Fat Brands *w Exp 07/16/202 (FATBW)
Greenwave Technology Solutio (GWAV)
Polished *w Exp 06/02/202 (POLWQ)
Sobr Safe (SOBR)
Mind Medicine Mindmed (MNMD)
Tc Biopharm Holdings *w Exp 02/08/202 (TCBPW)
Sellas Life Sciences Group I (SLS)
Medicenna Therapeutics Corp. (MDNAF)
Harbor Custom Development In *w Exp 10/04/202 (HCDZQ)
Hagerty *w Exp 12/02/202 (HGTY.WS)
Surrozen
Athenex
Surgepays *w Exp 10/22/202 (SURGW)

View all positions for Empery Asset Management

Top funds holding Sellas Life Sciences Group I

Alyeska Investment Group
Vanguard Group
Citadel Advisors
Opus Capital Group
Virtu Financial
Wells Fargo & Company
Charles Schwab Investment Management
Two Sigma Securities
Commonwealth Equity Services
Millennium Management
Brooklyn FI
Nemes Rush Group
Jpmorgan Chase & Co
Advisor Group Holdings
Royal Bank of Canada

View all funds holding Sellas Life Sciences Group I